Physician profile
Michael J Disher
NPI 1205828985
$2,570.02
in general payments reported to CMS, 2019-2025
14 companies · $660 in 2025
The $660 reported for 2025 was more than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $162 · 2021: $330 · 2022: $429 · 2023: $258 · 2024: $367 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,284.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Bionics, LLC | $1,270.55 | 2019-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Med-El Corporation | $518.43 | 2019-2024 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft |
| Cochlear Americas | $219.05 | 2019-2023 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Medtronic, INC. | $169.63 | 2022-2023 | Alar |
| Depuy Synthes Sales INC. | $108.66 | 2020 | |
| Integra Lifesciences Corporation | $81.26 | 2023-2025 | Integra, Relieva Spinplus Nav, Trudi Probe |
| Oticon Medical, LLC | $59.07 | 2019 | |
| Inspire Medical Systems, INC. | $30.68 | 2023 | Inspire |
| Smith+Nephew, INC. | $24.74 | 2025 | Stravix |
| Allergan, INC. | $23.74 | 2020 | |
| Abbvie INC. | $21.28 | 2021 | |
| Ethicon US, LLC | $16.99 | 2024 | Surgicel Nu-Knit |
| Kls-Martin L.P. | $13.96 | 2023 | |
| Novartis Pharmaceuticals Corporation | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Disher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.